Skip to main content
Join CMKC members for a complimentary virtual event on December 10, 11am ET: CM MythBusters: https://bit.ly/3YXJynA. This is a fantastic opportunity to connect, collaborate, and debunk common myths about continuous manufacturing!
18.227.209.101

Pharmaceutical manufacturing and the quality by design (QBD), process analytical technology (PAT) approach

By Murphy, Trevor; O’ Mahony, Niall; Panduru, Krishna; Riordan, Daniel; Walsh, Joseph

Published on

Abstract

This paper is the result of a literature review focusing on the application of process analytical technology (PAT) for the pharmaceutical industry in conjunction with the quality by design (QBD) framework. PAT and the QBD framework put forward by the FDA, offer a holistic approach to manufacturing pharmaceuticals, emphasising the understanding of process variables on the end products characteristics and transmitting this information upstream to control critical process parameters that effect the critical to quality attributes of a product. Key components of QBD are discussed and their potential impact on current manufacturing processes along with the technological capabilities of PAT and the benefits associated with real-time process monitoring and control.

Journal

Institute of Electrical and Electronics Engineers (IEEE). 2016

DOI

10.1109/ISSC.2016.7528465

Type of publication

Peer-reviewed journal

Affiliations

  • IMAR Technology Gateway Institute of Technology Tralee

Article Classification

Other

Classification Areas

  • PAT
  • Oral solid dose

Tags